Efficacy of lorlatinib in patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC) and ROS1 kinase domain mutations Meeting Abstract
| Authors: | Solomon, B. J.; Martini, J. F.; Ou, S. H. I.; Chiari, R.; Soo, R. A.; Bearz, A.; Li, S.; Thurm, H.; Lin, C. C.; Riely, G. J.; Bauer, T. M.; Shaw, A. T. |
| Abstract Title: | Efficacy of lorlatinib in patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC) and ROS1 kinase domain mutations |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy292.003 |
| Language: | English |
| ACCESSION: | WOS:000459277303151 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy292.003 |
| Notes: | Meeting Abstract: 1380PD -- Appears on page viii495 of the abstract book -- Source: Wos |
